Our Mission >>
November 20-22, 2020
November 28 – December 5, 2020
We invite you to read our blog from experts in diabetes management for our upcoming virtual webinar, “Advancing Strategies in the Management of Type 2 Diabetes.” This blog will feature weekly posts related to preventing hypoglycemia today, what you need to know about managing clinical inertia and insulin intensification, and the latest treatment options for type 2 diabetes based on the results of cardiovascular outcomes trials. Each blog will feature a prominent leader in the management of diabetes and cardiovascular complications.
Be sure to register for the upcoming live webinar on this same topic to be held on December 2 at 6:00 PM CET. Your blog comments will be addressed during the webinar.
Click here to read the blogs.
Click here to register for the live webinar.
Click here to view the program details.
Debido a la pandemia, hemos determinado que el curso se organizara de forma virtual. Para inscribirse al XXII Davidson-Mestman Curso Intensivo Virtual, haga clic en el siguiente enlace: (www.davidsonmestmancursointensivoendocrino2020.com/registro/)
Haga clic en la foto para ver la invitacion de los doctores Davidson, Ayala y Burguera.
During the American Diabetes Association’s 80th Scientific Sessions, a virtual experience from June 12-16, 2020, the University of Texas Southwestern Medical Center and Worldwide Initiative for Diabetes Education jointly sponsored a CME webinar in Spanish for Spanish-speaking attendees, “Estrategias del Siglo XXI para Reducir el Riesgo de Hipoglucemia con Terapia de Insulina.” This webinar is now available on demand for viewing at your convenience.
By clicking below, you can register and view this free program, download the slide content, and subsequently receive CME credits upon successful completion of the evaluation documents.
Managing type 2 diabetes during pregnancy can be especially challenging, both for the mother and the health care provider. In this month’s column, Dr. Pei Lin Chan discusses the role of metformin in pregnant women with type 2 diabetes as well as gestational diabetes. Please take a moment to read her column and check back here monthly for her continuing editorial contributions.
Click here to read the column.
Click here for Dr. Chan’s previous columns.
As we now understand that there is a strong correlation between cardiovascular complications and diabetes, we have expanded our mission to include cardiovascular and renal disease. To that end, we have created a specialized subgroup within Worldwide Diabetes, named “Worldwide CardioDiabetes.” Led by a world-renowned Board of Directors, our first initiative was an international congress in partnership with the Sociedad Mexicana de Nutrición y Endocrinología, September 27-28, 2019, in Guadalajara, Mexico. The two-day course included 20 international and national speakers and was attended by 250 health care professionals. A 2020 international congress is currently being planned.
Click here to visit the Worldwide CardioDiabetes webpage, where you can learn more information about its mission, Board of Directors, and important resources.
This interactive video program will inform you on new treatment options for type 2 diabetes that promote long-term glycemic control with lower hypoglycemia risk as well as low risk for cardiovascular events. It features prominent experts in the field of diabetes and cardiology.
For the second year, Worldwide Diabetes will award a scholarship to a young endocrine fellow practicing in a developing country to attend the 81st Scientific Sessions of the American Diabetes Association in 2021 and work with the foundation as an editorial contributor. Full details and the scholarship application can be accessed here.